FMO5 and diabetes mellitus: Visfatin, an adipokine reported in obesity and diabetes mellitus, was shown to increase sphingomyelinase activity, leading to an increased production of ceramide and clustering of NADPH oxidase subunits gp91phox and p47phox in membrane rafts, forming MRRSP.